| Institution Affiliations: |
| Assistant Professor of Medicine, Dartmouth Medical School |
| Attending in Hematology and Oncology, White River Junction VA Medical Center |
| Specialty: Hematology and Oncology
|
| Joined Staff: 2003 |
| Cancer Center Membership: |
|
|
| Board Certified: |
| Internal Medicine |
| Hematology and Oncology |
|
| 1987-1993. "Carol Davila" Faculty of Medicine, Bucharest, Romania, MD Degree Summa Cum Laude |
| 1996-1999 Internal Medicine Residency Program at New York University-Veterans Affairs Medical Center, New York, including rotations at Manhattan Veterans Affairs Medical Center, Bellevue Hospital, Tisch Hospital, and Memorial Sloan Kettering Hospital (Leukemia and Breast cancer services) |
| 1993-1996 Internal Medicine Residency Program at University Hospital and Fundeni Hospital, Bucharest, Romania |
| 1999-2002 Fellowship in Hematology & Oncology at New York University, New York, which included rotations at Manhattan Veterans Affairs Medical Center, Bellevue Hospital, Tisch Hospital, and Brooklyn Hospital - Center Bone Marrow Transplant Unit |
| Selected Publications: |
| 2004
"Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients with Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial." Journal of Clinical Oncology 22:1301-1307, 2004
2002
"Standard Chemotherapy Doses and Schedules" - New York University Cancer Institute Bellevue hospital center guide, New York. Coauthors: Sylvia Adams, Teresa Ryan, Tatiana Feldman, Maytree Hazarika, and Janice Lu |
|
Research Interests:
|
2003 – present : Co-PI
Dartmouth Medical School trial. A Multicenter, randomized Phase III Study of Taxotere and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer
2003 – present : Co-PI
Dartmouth Medical School trial. Effect of a Single Dose of Low Molecular Weight Heparin (Enoxaparin) on Plasma Markers of Angiogenesis and Hemostatic Activation in Patients with Advanced Non-Small Cell Lung Cancer
2003 – present : Co-PI
Dartmouth Medical School trial. A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using Juven® Nutritional Supplement
2003 – present : Co-PI
Dartmouth Medical School trial. Atorvastatin as a Signal transduction Inhibitor for Treatment of Advanced Hematologic Diseases
|
|
|
|
|
Mailing Address:
VAMC
215 North Main Street
White River Junction, VT 05009-0001
|
|
